Glialogix 20logo3


Glialogix offers a unique opportunity in Progressive Multiple Sclerosis, a multi-billion dollar market with no effective therapies.

  • Stage Prototype Ready
  • Industry Biotechnology
  • Location San Francisco, CA, US
  • Currency USD
  • Founded June 2012
  • Employees 3
  • Website

Only investors on Gust who have been granted access can view this content.

Interested in this startup? Sign In or Sign Up to request more information.